SCHEMBL24253970

SCHEMBL24253970

CCc1cc(OC(=O)N2CCC(N3CCCCC3)CC2)ccc1N

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.58
CYP1A2 P05177 1/20 0.58
LRRK2 Q5S007 1/20 0.48
MAPT P10636 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MEN1 O00255 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
MGLL Q99685 3/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
L3MBTL3 Q96JM7 5/20 0.45
L3MBTL1 Q9Y468 5/20 0.45
ACHE P22303 1/20 0.44
MBTD1 Q05BQ5 3/20 0.44
HRH3 Q9Y5N1 2/20 0.44
MAPK1 P28482 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24253870 0.86 CYP2D6 (0.56) CYP2D6CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL24253971 0.81 CYP2D6 (0.48) CYP2D6CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL4018680 0.80 CYP1A2 (0.69) CYP2D6CYP1A2LRRK2MAPTSMN1; SMN2
SCHEMBL24253780 0.79 CYP2D6 (0.48) CYP2D6CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL13645932 0.78 CYP1A2 (0.69) CYP2D6CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL31323039 0.77 SMN1; SMN2 (0.66) CYP2D6CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL21766914 0.75 CYP2D6 (0.65) CYP2D6CYP1A2MAPTSMN1; SMN2MEN1
SCHEMBL8149995 0.74 CYP1A2 (0.67) CYP2D6CYP1A2SMN1; SMN2MEN1KMT2A
SCHEMBL310306 0.74 L3MBTL3 (0.55) LRRK2MAPTMEN1HTTKMT2A
SCHEMBL4993839 0.74 CYP1A2 (0.67) CYP2D6CYP1A2SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022034587-A1 Traf2- AND Nck-INTERACTING KINASE (TNIK) INHIBITORS AND USES THEREOF TNIK THERAPEUTICS LTD (IL) 2022-02-17 WO disclosed